The biological seed treatment market was estimated at USD 739.3 Million in 2017, and is projected to reach USD 1,251.4 Million by 2022, at a CAGR of 11.10%. The market is influenced by the adoption of sustainable agricultural practices, along with strong investments being made by major market players in the research and development of these products.

Get Free 10% Customization:
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=162422288

The global market, based on function, has been segmented into biofertilizers, biostimulants, bioinsecticides, biofungicides, and others. Biofertilizers are rapidly gaining pace because of their potential to provide disease resistance in crops, while improving crop quality and yield. Due to this trend and the registration & commercialization of new varieties of biofertilizers, this segment was estimated to account for a large share in the market in 2017.

The global market, by type, has been segmented into microbials, botanicals, and others (biofermentation products and natural polymers & derivatives). The microbials industry dominated the market in 2016, due to the increasing demand for microbial seed treatments, in field crops such as soybean and corn.

Make an Inquiry:
 https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=162422288

North America accounted for the largest market share in 2016, and is also projected to be fastest-growing in the biological seed treatment market in the next five years. The dominant share of the North American region is attributed to the increasing ban on the usage of certain chemical formulations in North American countries. A growing trend towards the development of sustainable options to mitigate environmental risks, is expected to further improve market demand for these products.

The global market for biological seed treatment is dominated by large-scale players such as BASF (Germany), Bayer AG (Germany), Syngenta (Switzerland), Monsanto BioAg (US), DuPont (US), and Italpollina (Italy). Koppert (Netherlands), Incotec (Netherlands), Plant Health Care (US), Precision Laboratories (US), Verdesian Life Sciences (US), and Valent Biosciences (US) are a few other key market players that also have a significant share in the biological seed treatment market.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]